Medicines Co. | Mutual Funds
Mutual Funds that own Medicines Co.
Vanguard Health Care Fund
5,564,220
7.54%
0
0.44%
06/30/2018
iShares Core S&P Small Cap ETF
3,572,435
4.84%
1,011
0.3%
09/06/2018
Fidelity Growth Company Fund
2,225,711
3.02%
-12,077
0.18%
07/31/2018
Vanguard Total Stock Market Index Fund
1,678,456
2.27%
1,794
0.01%
07/31/2018
Vanguard Small Cap Index Fund
1,668,343
2.25%
23,549
0.07%
07/31/2018
iShares Russell 2000 ETF
1,445,515
1.96%
-771
0.12%
09/06/2018
Fidelity Select Health Care Portfolio
1,000,000
1.36%
0
0.52%
07/31/2018
Fidelity Select Biotechnology Portfolio
977,308
1.32%
0
0.42%
07/31/2018
Vanguard Small Cap Growth Index Fund
951,501
1.29%
15,183
0.15%
07/31/2018
Vanguard Extended Market Index Fund
860,244
1.17%
7,900
0.05%
07/31/2018
| Address |
8 Sylvan Way
Parsippany New Jersey 07054
United States
|
|
Employees
|
- |
| Website |
http://www.themedicinescompany.com |
| Updated |
07/08/2019 |
| The Medicines Co. operates as a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. |
